Literature DB >> 18602664

Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance.

Anita Iyer1, Marie E Robert, Carlo B Bifulco, Ronald R Salem, Dhanpat Jain.   

Abstract

Differentiating focal nodular hyperplasia from hepatic adenoma can be challenging. Cytokeratin 7, neuronal cell adhesion molecule, and cytokeratin 19 are differentially expressed in hepatocytes, biliary epithelium, and possibly hepatic progenitor/stem cells. CD34 is known to have altered expression patterns in the hepatic endothelium in conditions associated with abnormal perfusion and in hepatocellular carcinoma. The purpose of this study was to examine the expression pattern of these markers in focal nodular hyperplasia and hepatic adenoma and assess their diagnostic use. Ten resection specimens each of hepatic adenoma and focal nodular hyperplasia (including a case of telangiectatic focal nodular hyperplasia) were selected for the study. Immunohistochemical analysis was performed using antibodies against cytokeratin 7, cytokeratin 19, neuronal cell adhesion molecule, and CD34 on formalin-fixed, paraffin-embedded sections from each case. The staining patterns and intensity for each marker were analyzed. In hepatic adenoma, the cytokeratin 7 stain revealed strong positivity in hepatocytes in patches, with a gradual decrease in the staining intensity as the cells differentiated towards mature hepatocytes. Although bile ducts were typically absent in hepatic adenoma, occasional ductules could be identified with cytokeratin 7 stain. In focal nodular hyperplasia, cytokeratin 7 showed strong staining of the biliary epithelium within the fibrous septa and staining of the peripheral hepatocytes of most lobules that was focal and weaker than hepatic adenoma. Cytokeratin 19 and neuronal cell adhesion molecule showed patchy and moderate staining in the biliary epithelium of the ductules in focal nodular hyperplasia. While in the hepatic adenoma, cytokeratin 19 showed only rare positivity in occasional cells within ductules, and neuronal cell adhesion molecule marked occasional isolated cells in the lesion. CD34 showed staining of sinusoids in the inflow areas (periportal areas) in both focal nodular hyperplasia and hepatic adenoma. One case of telangiectatic focal nodular hyperplasia revealed both hepatic adenoma-like and focal nodular hyperplasia-like staining patterns. Distinct cytokeratin 7, cytokeratin 19, and neuronal cell adhesion molecule staining patterns are seen in hepatic adenoma and focal nodular hyperplasia possibly suggest activation of different subsets of hepatic progenitor/stem cell and can be diagnostically useful.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602664      PMCID: PMC3738023          DOI: 10.1016/j.humpath.2008.01.015

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  18 in total

Review 1.  Update on hepatic stem cells.

Authors:  M R Alison; R Poulsom; S J Forbes
Journal:  Liver       Date:  2001-12

Review 2.  Hepatic stem cells: a review.

Authors:  C J Vessey; P M de la Hall
Journal:  Pathology       Date:  2001-05       Impact factor: 5.306

3.  Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver.

Authors:  Hongchao Zhou; Leslie E Rogler; Lewis Teperman; Glyn Morgan; Charles E Rogler
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

4.  Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy.

Authors:  C S Kong; M Appenzeller; L D Ferrell
Journal:  Acta Cytol       Date:  2000 Mar-Apr       Impact factor: 2.319

5.  Immunohistochemical patterns of human liver sinusoids under different conditions of pathologic perfusion.

Authors:  I Theuerkauf; H Zhou; H P Fischer
Journal:  Virchows Arch       Date:  2001-05       Impact factor: 4.064

6.  Hepatic progenitor cells in hepatocellular adenomas.

Authors:  L Libbrecht; R De Vos; D Cassiman; V Desmet; R Aerts; T Roskams
Journal:  Am J Surg Pathol       Date:  2001-11       Impact factor: 6.394

7.  The canals of Hering and hepatic stem cells in humans.

Authors:  N D Theise; R Saxena; B C Portmann; S N Thung; H Yee; L Chiriboga; A Kumar; J M Crawford
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

8.  Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.

Authors:  David Cassiman; Louis Libbrecht; Valeer Desmet; Carl Denef; Tania Roskams
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

9.  Liver cell adenoma with malignant transformation: a case report.

Authors:  Masahiro Ito; Makoto Sasaki; Chun Yang Wen; Masahiro Nakashima; Toshihito Ueki; Hiromi Ishibashi; Michitami Yano; Masayoshi Kage; Masamichi Kojiro
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

10.  Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma.

Authors:  Valerie Paradis; Asmae Benzekri; Delphine Dargère; Ivan Bièche; Ingrid Laurendeau; Valerie Vilgrain; Jacques Belghiti; Michel Vidaud; Claude Degott; Pierre Bedossa
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

View more
  7 in total

1.  Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor?

Authors:  Riccardo Masetti; Carlotta Biagi; Katharina Kleinschmidt; Arcangelo Prete; Federico Baronio; Antonio Colecchia; Davide Festi; Andrea Pession
Journal:  Eur J Pediatr       Date:  2011-01-12       Impact factor: 3.183

2.  Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma.

Authors:  Caecilia Hc Sukowati; Natalia Rosso; Lory S Crocè; Claudio Tiribelli
Journal:  World J Hepatol       Date:  2010-03-27

3.  Senescence markers in focal nodular hyperplasia of the liver: pathogenic considerations on the basis of immunohistochemical results.

Authors:  Helmut Denk; Daniela Pabst; Peter M Abuja; Robert Reihs; Brigitte Tessaro; Kurt Zatloukal; Carolin Lackner
Journal:  Mod Pathol       Date:  2021-10-13       Impact factor: 7.842

4.  Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours.

Authors:  Renee G H M van Sprundel; Ted S G A M van den Ingh; Valeer J Desmet; Azeam Katoonizadeh; Louis C Penning; Jan Rothuizen; Tania Roskams; Bart Spee
Journal:  Comp Hepatol       Date:  2010-02-18

5.  Molecular pathology of hepatic neoplasms: classification and clinical significance.

Authors:  Zenta Walther; Dhanpat Jain
Journal:  Patholog Res Int       Date:  2011-04-07

Review 6.  Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver.

Authors:  Jiliang Feng; Ruidong Zhu; Yu Yin; Shanshan Wang; Lei Zhou; Fudong Lv; Dawei Zhao
Journal:  J Hepatocell Carcinoma       Date:  2021-12-07

7.  Gremlin in the pathogenesis of hepatocellular carcinoma complicating chronic hepatitis C: an immunohistochemical and PCR study of human liver biopsies.

Authors:  Maha Guimei; Nahed Baddour; Dalal Elkaffash; Laila Abdou; Yousry Taher
Journal:  BMC Res Notes       Date:  2012-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.